CX Institutional’s Enovis ENOV Stock Holding History

CX Institutional’s Portfolio ENOV Stock Details ENOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-13	Closed	-$1K	–	660
2022 Q2	$1K	Buy	+13	New	+$838	﹤0.01%	1132

Other funds holding ENOV

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

CCM

Channing Capital Management Chicago, Illinois $3.91B AUM 34.32% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

CX Institutional's ENOV Position: Q3 2022 in Review

CX Institutional sold out of Enovis (ENOV) in Q3 2022, closing a stake of 13 shares — an estimated $1K sold.

CX Institutional first reported a position in ENOV in Q2 2022 and held it in 1 quarter. The position peaked at $1K in Q2 2022. 242 funds tracked by Wall St. Rank hold ENOV as of Q3 2022.

CX Institutional reported no remaining Enovis position as of Q3 2022 after selling out during the quarter.
CX Institutional sold 13 Enovis shares in Q3 2022, an estimated $1K.
CX Institutional first reported a position in Enovis in Q2 2022 and held it in 1 quarter.
CX Institutional's Enovis position peaked at $1K in Q2 2022.
242 funds tracked by Wall St. Rank held Enovis as of Q3 2022.

Based on CX Institutional's 13F filing for Q3 2022, filed 4 Nov 2022.